Page 129 - Read Online
P. 129

Page 8 of 8                                              Myint et al. Mini-invasive Surg 2018;2:34  I  http://dx.doi.org/10.20517/2574-1225.2018.52


               Ethical approval and consent to participate
               Ethic approval (01-02/26). Consent was obtained in this study.


               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2018.


               REFERENCES
               1.   Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, Arnold D; ESMO Guidelines Committee. Rectal cancer: ESMO
                   clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017;28:iv22-40.
               2.   Moran B, Karandikar S, Geh I. Association of coloproctology of great Britain & Ireland (ACPGBI): guidelines for the management of
                   cancer of the colon, rectum and anus (2017) - introduction. Colorectal Dis 2017;19:6-8.
               3.   Renehan AG, Malcomson L, Emsley R, Gollins S, Maw A, Myint AS, Rooney PS, Susnerwala S, Blower A, Saunders MP, Wilson MS,
                   Scott N, O’Dwyer ST. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the
                   OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol 2016;17:174-83.
               4.   Sun Myint A, Smith FM, Gollins SW, Wong H, Rao C, Whitmarsh K, Sripadam R, Rooney P, Hershman MJ, Fekete Z, Perkins K,
                   Pritchard DM. Dose escalation using contact X-ray brachytherapy (Papillon) for rectal cancer: does it improve the chance of organ
                   preservation? B J Radiol 2017;90:20170175.
               5.   Habr-Gama A, Gama-Rodrigues J, São Julião GP, Proscurshim I, Sabbagh C, Lynn PB, Perez RO. Local recurrence after complete
                   clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease
                   control. Int J Radiat Oncol Biol Phys 2014;88:822-8.
               6.   Duldulao MP, Lee W, Streja L, Chu P, Li W, Chen Z, Kim J, Garcia-Aguilar J. Distribution of residual cancer cells in the bowel wall
                   after neoadjuvant chemoradiation in patients with rectal cancer. Dis Colon Rectum 2013;56:142-9.
               7.   Sun Myint A, Smith FM, Gollins S, Wong H, Rao C, Whitmarsh K, Sripadam R, Rooney P, Hershman M, Pritchard DM. Dose
                   escalation using contact X-ray brachytherapy after external beam radiotherapy as nonsurgical treatment option for rectal cancer:
                   outcomes from a single-center experience. Int J Radiat Oncol Biol Phys 2018;100:565-73.
               8.   van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, Habr-Gama A, Perez
                   RO, Renehan AG, van de Velde CJH; IWWD Consortium. Long-term outcomes of clinical complete responders after neoadjuvant
                   treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet
                   2018;391:2537-45.
               9.   NICE. Low energy contact X-ray brachytherapy (the Papillon technique) for early-stage rectal cancer. Available from: http://www.
                   contactpapillon.com/wp-content/uploads/2016/04/NICE-Papillon-guidance-Sept-2015.pdf. [Last accessed on 17 Sep 2018]
               10.  Smith FM, Chang KH, Sheahan K, Hyland J, O’Connell PR, Winter DC. The surgical significance of residual mucosal abnormalities in
                   rectal cancer following neoadjuvant chemoradiotherapy. Br J Surg 2012;99:993-1001.
               11.  Hershman MJ, Sun Myint A. Salvage surgery after inadequate combined local treatment for early rectal cancer. Clin Oncol (R Coll
                   Radiol) 2007;19:720-3.
               12.  Dhadda AS, Martin A, Killeen S, Hunter IA. Organ preservation using contact radiotherapy for early rectal cancer: outcomes of patients
                   treated at a single centre in the UK. Clin Oncol (R Coll Radiol) 2017;29:198-204.
               13.  Frin AC, Evesque L, Gal J, Benezery K, François E, Gugenheim J, Benizri E, Château Y, Marcié S, Doyen J, Gérard JP. Organ or
                   sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients. Eur J Cancer
                   2017;72:124-36.
               14.  NICE. Colorectal cancer: diagnosis and management. Available from: https://www.nice.org.uk/guidance/cg131. [Last accessed on 17
                   Sep 2018]
               15.  General Medical Council. Ethical guidance for doctors. Available from: https://www.gmc-uk.org/ethical-guidance/ethical-guidance-for-
                   doctors. [Last accessed on 17 Sep 2018]
               16.  BMJ Publishing Group Ltd. When surgeons unwittingly don’t obtain informed consent. Available from: https://blogs.bmj.com/
                   bmj/2017/10/06/fraser-smith-and-david-locke-when-surgeons-unwittingly-dont-obtain-informed-consent/. [Last accessed on 17 Sep
                   2018]
               17.  U.S. National Library of Medicine. European phase III study comparing, in association with neoadjuvant chemoradiotherapy, a radiation
                   dose escalation using 2 different approaches: external beam radiation therapy versus endocavitary radiation therapy with contact
                   X-ray brachytherapy 50 kV for patients with rectal adenocarcinoma cT2-T3 a,b < 5cm in diameter in distal and middle rectum.Organ
                   preservation for early rectal adenocarcinoma. Available from: https://www.clinicaltrials.gov. [Last accessed on 17 Sep 2018]
   124   125   126   127   128   129   130   131   132   133   134